DESIGN
- Design structure projects for experimental success
- Incorporate wider scientific context & goals of project team
- Leverage broad drug discovery experience
- Provide scientific & strategic value
Opilio helps companies harness the value of structural biology efficiently and economically.
Jeremiah Joseph, Founder
Opilio (ōpiliō, Latin for "shepherd"), was founded in 2023, with a vision to help companies harness the value of structural biology efficiently and economically.
Structural biology powerfully provides concrete visuals: how a small molecule engages its protein target, how an antibody binds its cognate antigen, how biomolecular complexes assemble. These pictures can stimulate scientific creativity, support confident decision making, and fast-track projects.
Opilio's founder, Jeremiah Joseph, has over 25 years of post-PhD experience, spanning structural biology, protein science, in vitro pharmacology, and management (people/data/projects/CROs) - all this acquired in pharma, biotech, and academia.
Opilio offers his on-demand expertise to manage and enable in-house and outsourced projects on a fractional FTE basis: a cost-effective, win-win arrangement that keeps critical IP closer to home.
Quick access to Opilio-hosted resources.
Structural Biology Consulting